TP53 and cancer: In the rare prostatic small cell neuroendocrine carcinoma, the absence or mutation of p53 deregulated expression of miR-25 and the E3 ligase FBXW7 results in elevated levels of AURKA and enhancement of cancer cell proliferation and aggressive behaviour [276].